Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

ICON Acquires Healthcare Discoveries
February 12, 2008
ICON has acquired Healthcare Discoveries, Inc., a wholly owned subsidiary of Catalyst Pharma Group, Inc., for $12 million in cash, and if certain performance milestones are achieved in 2008, a further consideration of as much as $10 million. Healthca…   Read More »
Merck To Pay $671 Million In Fraud Settlement
February 8, 2008
Merck has agreed to pay more than $671 million to settle allegations of fraud concerning Medicaid and other public healthcare programs across the U.S., according to a federal Settlement Agreement. According to qui tam lawyers Steven H. Cohen, Mark Kl…   Read More »
PPD To Acquire InnoPharm
February 7, 2008
PPD, Inc. has signed an agreement to acquire InnoPharm Ltd., an independent CRO based in Smolensk, Russia. The acquisition will expand PPD's global reach with offices in both Russia and Ukraine.     InnoPharm offers Phase II-IV cli…   Read More »
Cook Pharmica To Expand Bio-Facility
February 7, 2008
Cook Pharmica, the biopharmaceutical contract manufacturing division of Cook Medical, will invest $80 million in an 80,000-sq.-ft. expansion at its existing site in Bloomington, IN. The expansion is expected to add another 200 jobs when completed and…   Read More »
DSM To Make Steriles For APT
February 6, 2008
DSM Pharmaceuticals, Inc. has signed a manufacturing agreement with APT Pharmaceuticals, Inc. DSM will produce the commercial drug supply as a sterile product for pulmonary delivery for APT. The agreement will utilize DSM's commercial facilities in G…   Read More »
Althea To Produce Lead Onco-Drug For Quintessence Biosciences
February 5, 2008
Althea Technologies, Inc. has entered a manufacturing supply agreement with Quintessence Biosciences to produce the firm's first drug candidate, QBI-139. The drug is effective in cancer models against a broad range of solid tumors. Quintessence plans…   Read More »
Tufts Study Finds Pharma/Biopharma Organization Structure Affects Performance
February 5, 2008
A recent study by the Tufts Center for the Study of Drug Development found that how drug developers organize their companies affects operational and financial performance. The research, developed by Tufts CSDD and PRTM, an operations management consu…   Read More »
Azopharma Acquires Clinical Site In Daytona Beach
February 1, 2008
Azopharma Product Development Group, Inc. has acquired Coastal Medical Research, Inc. (CMR), a clinical pharmacology facility in Daytona Beach, FL. The facility will operate under AvivoClin Clinical Services, Azopharma's clinical pharmacology divisio…   Read More »
Laureate To Manufacture Arius Antibody
January 31, 2008
Laureate Pharma, Inc. has entered into a cGMP contract manufacturing agreement with Arius Research, Inc. to produce Arius' IgG1 humanized antibody. Arius' Trop-2 antibody program targets a novel marker that has been linked to aggressive cancers inclu…   Read More »
Catalent, Secure Symbology Employ Track And Trace For BI Products
January 29, 2008
Catalent Pharma Solutions, in partnership with Secure Symbology, Inc. (SSI), entered an agreement to employ Track and Trace serialization technology for the packaging of Biogen Idec products. Successful implementation of the technology will make Biog…   Read More »
MDS Expands Latin American Presence
January 28, 2008
MDS Pharma Services has opened an office in Sao Paulo, Brazil, to expand its global clinical trial management capabilities.     "Our new office in Sao Paulo is a key component of our global expansion strategy. It allows MDS Ph…   Read More »
IPS Implements Design Recognition Program
January 28, 2008
Integrated Project Services (IPS) has implemented a Sustainable Design Recognition program, designed to raise awareness of the environmental impact its designs have and also to offer clients a new way of looking at hi-tech, high performance facilitie…   Read More »
MDS Opens Another West Coast Phase I Clinic
January 25, 2008
MDS Pharma Services has added a $25 million, 300-bed, Phase I facility in Tempe, AZ. The new facility more than doubles the company's Phase I capacity in Phoenix to a total of 420 beds. Its current Phoenix workforce of more than 150 could triple when…   Read More »
Cobra To Manufacture GenVec Drug Candidate
January 25, 2008
Cobra Biomanufacturing has entered into a manufacturing development agreement with GenVec, Inc. for TNFerade, GenVec’s lead candidate for pancreatic cancer. The agreement includes technology transfer, scale-up, and validation of the manufacturi…   Read More »
PPD Expands Lab Services Into China
January 24, 2008
PPD, Inc. has entered into an exclusive agreement with Peking Union Lawke Biomedical Development Ltd. (PUL), expanding its global central lab services into China. The agreement allows PPD to start providing its full range of central lab services in C…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: